Lentiviral Expression of ANKRD26 Variants
Corresponding Organization :
Other organizations : Boston Children's Hospital, Harvard University, Dana-Farber Cancer Institute, Broad Institute, Massachusetts Institute of Technology, Massachusetts General Hospital
Variable analysis
- CDNA encoding full-length or truncated exon11+ ANKRD26
- WAC-ANKRD26 fusion starting from exon 10 of ANKRD26
- Overexpression of relevant constructs in HSPCs at a multiplicity of infection of 50
- Effects upon signaling activity downstream of the TPO receptor
- HSPCs were cultured for 5 d after transduction in serum-free StemSpan II medium (STEMCELL Technologies) supplemented with CC100 cytokine cocktail (STEMCELL Technologies), 50 ng/ml TPO (PeproTech), and 35 nM UM171 (Bao et al., 2020 (link))
- Cells were serum starved for 2 h followed by stimulation with TPO at 50 ng/ml for 15 min
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!